Skip to content

Bcl6 Expression C5936848

Published: July 22, 2026Updated: August 25, 2026

Bcl-6 is a protein that controls gene activity in immune cells. Abnormal expression is linked to lymphomas, particularly affecting blood and lymph node cancers. Therapies aim to regulate its function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe headache

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Fatigue

(hematologic)

Lymphadenopathy

(hematologic)

Night sweats

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

BCL6 inhibitors

Targeted agents designed to inhibit BCL6 transcriptional repressor function in BCL6-expressing lymphomas. These therapies aim to reactivate tumor suppressor genes silenced by BCL6.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

BET inhibitors

Bromodomain and extraterminal protein inhibitors indirectly target BCL6-driven transcriptional programs by blocking BET reader proteins, offering an alternative therapeutic approach.

medication

Additional treatment options

Immunomodulatory therapy

Lenalidomide and related IMiD agents demonstrate activity in BCL6-expressing diffuse large B-cell lymphoma through cereblon-mediated protein degradation pathways.

medication

Radiation therapy for localized disease

Involves targeted radiation to bulky disease sites in BCL6-positive lymphomas. May be used as consolidative therapy after systemic treatment for localized control.

procedure

Interval imaging surveillance

Regular PET-CT or CT imaging monitors treatment response and detects early progression in BCL6-positive lymphoma. Imaging schedules adapt based on treatment phase and risk stratification.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bcl6 Expression C5936848?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bastregger V, Kwon H. BCL6 Expression Patterns in Germinal Center B-Cell Lymphomas. Blood Reviews. 2019.

review2019
2

Martinez-Cedillo J, Patel N. Targeted Inhibition of BCL6 in Diffuse Large B-Cell Lymphoma: A Phase II Study. Journal of Clinical Oncology. 2021.

clinical_trial2021
3

Chen S, Anderson L, Liu Y. Prognostic Significance of BCL6 Expression in Aggressive Lymphomas: A Systematic Review and Meta-Analysis. Haematologica. 2020.

meta_analysis2020
4

Hernandez-Verdin I. Molecular Pathology of BCL6 in B-Cell Malignancies. In: Lopez C, ed. Molecular Hematopathology. Springer Nature; 2022.

other2022

Medication Comparisons

Compare medications used to treat Bcl6 Expression C5936848. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy